Get access to our best features
Get Started
Subscribe
Israel-Hamas Conflict
Joe Biden
US Economy
Donald Trump
US Politics
Independence Day
Democratic Party
Parade
Kamala Harris
Heatwaves
US Social Issues
White House
US Crime
Get access to our best features
Get Started
Published 15 days ago

WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs

  • The World Health Organization and Eli Lilly and Co. Caution against counterfeit weight-loss and diabetes drugs.
  • WHO reports fake semaglutide, found in Novo Nordisk's drugs, circulating globally since 2022.
  • Eli Lilly asserts exclusivity in supplying drugs, warning against counterfeit tirzepatide from non-official sources.
Insights by Ground AI
Does this summary seem wrong?

0 Articles

All
Left
Center
Right
Associated Press NewsAssociated Press News

WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs

The World Health Organization and drugmaker Eli Lilly and Co. are warning patients to be wary of fake versions of weight-loss and diabetes medicines

15 days ago·United States
Read Full Article
abc Newsabc News

WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs

The World Health Organization and drugmaker Eli Lilly and Co. are warning patients to be wary of fake versions of weight-loss and diabetes medicines

15 days ago·United States
Read Full Article
KIFIKIFI

WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs

The Associated Press The World Health Organization and drugmaker Eli Lilly and Co. are warning patients to be wary of fake versions of weight-loss and diabetes medicines. WHO said Thursday that it has fielded reports of fake semaglutide _ the active ingredient in Novo Nordisk’s Wegovy and Ozempic. Lilly says in an open letter that it is “deeply concerned” about growing online sales and social media posts involving fake or compounded versions of …

15 days ago·Idaho Falls, United States
Read Full Article
KVIAKVIA

WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs

The Associated Press The World Health Organization and drugmaker Eli Lilly and Co. are warning patients to be wary of fake versions of weight-loss and diabetes medicines. WHO said Thursday that it has fielded reports of fake semaglutide _ the active ingredient in Novo Nordisk’s Wegovy and Ozempic. Lilly says in an open letter that it is “deeply concerned” about growing online sales and social media posts involving fake or compounded versions of …

15 days ago·Panama City, United States
Read Full Article
Flin Flon ReminderFlin Flon Reminder

WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs

The World Health Organization and drugmaker Eli Lilly and Co. are warning people to be wary of fake versions of popular weight-loss and diabetes medicines.

15 days ago·Flin Flon, Canada
Read Full Article
Rocky Mountain OutlookRocky Mountain Outlook

WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs

The World Health Organization and drugmaker Eli Lilly and Co. are warning people to be wary of fake versions of popular weight-loss and diabetes medicines.

15 days ago
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 59% of the sources are Center
59% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

DiabetesDiabetes
Novo NordiskNovo Nordisk
World Health OrganizationWorld Health Organization
Eli LillyEli Lilly
HealthHealth
MedicalMedical
United StatesUnited States
Trending Topics
Ground News logo
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc.
News
For You
Search
BlindspotLocal